The treatment approaches for lung cancer are rapidly evolving, and include integration of new systemic therapies (e.g. immunotherapy and targeted therapies) into combined modality approaches for non-metastatic disease and ablative radiation therapy approaches for oligo-metastatic disease.

Patients diagnosed with head and neck cancers undergo treatments which include various combinations of surgery, radiation and chemotherapy. These treatments result in short and long-terms side effects and complications that could be life altering for these patients.

This educational activity will focus on the identification and management of oral and swallowing complications caused by cancer-directed therapy for patients with head and neck cancer.

The gaps in practice include the proper integration of new data with existing trials and practices in viral-driven head and neck cancers.

This session reviews head and neck cancers from a patient perspective.

This case-based panel will outline the multidisciplinary approach to patients with salivary cancer.  Perspective will be provided by experts in the field on topics such as extent of primary tumor surgery and management of cervical lymphatics, as well as indications for adjuvant radiation therapy

There is a great need for improvement in outcomes for HPV negative HNSCC patients. There are ongoing efforts to better understand the biology of HPV negative HNSCC, and reported and ongoing therapeutic clinical trials to try to improve outcomes in this patient population.

The treatment of early and advanced thyroid cancer is rapidly changing due to developments in targeted drug therapy and new surgical and minimally invasive approaches.  This session will familiarize the learner with the new targeted agents and their appropriate place in the treatment algorithms. 

This session will review the latest science in the field of head and neck cancer.